DOTBIO PTE. LTD.
Country of registration | Singapore |
Registration number | 201715654D |
Local SIC | |
Incorporation date | 6 Jun 2017 |
Company age | 8 years 11 months |
Official entity type | Private Limited Company |
No. of officers | 33 |
Contact
45 NORTH CANAL ROAD, #01-01, LEW BUILDING, Singapore 059301
This is the legal entity page of DOTBIO PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- DOTBIOView MoreSingaporeDotBio is a biotechnology company focused on developing novel immuno-oncology drugs using its proprietary DotBody technology. Dot Bodies are multi-specific, humanized, and highly stable domain therapeutic antibodies that have the potential to revolutionize cancer treatment. Founded by experts in protein and antibody engineering, DotBio aims to harness the power of the body's immune system to fight cancer with maximum efficiency.
Auditor | P G WEE PARTNERSHIP LLP |
Revenue | < 1m |
Share Capital - Ordinary shares | SGD 4,124,250 |
Share Capital - Preference shares | USD 7,690,755 |
Frequently Asked Questions (FAQ)
- What is the address of DOTBIO PTE. LTD.?
- Where is DOTBIO PTE. LTD.'s headquarter?
- What is DOTBIO PTE. LTD.'s contact number?
- What DOTBIO PTE. LTD.'s spending power?
- Does DOTBIO PTE. LTD. have a presence in the domain it operates in?

